NCT00134914View on ClinicalTrials.gov

Effects of Buprenorphine/Naloxone Administered in Different Ways For Treating Opioid Dependence

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

August 31, 1996

Primary Completion Date

April 30, 1998

Study Completion Date

May 31, 1998

Conditions
Opioid-Related Disorders
Interventions
DRUG

Buprenorphine

single doses given by sublingual and parenteral routes

Trial Locations (1)

21224 6823

Johns Hopkins University (BPRU) Bayview Campus, Baltimore

All Listed Sponsors
lead

National Institute on Drug Abuse (NIDA)

NIH

NCT00134914 - Effects of Buprenorphine/Naloxone Administered in Different Ways For Treating Opioid Dependence | Biotech Hunter | Biotech Hunter